|

ACE1831 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Acepodia Biotech, Inc.1

Indications

  • Burkitt Lymphoma1
  • Primary Mediastinal Large B-Cell Lymphoma1
  • High-grade B-cell Lymphoma1
  • DLBCL1
  • Non-hodgkin Lymphoma1

Orlando, Florida1 trial

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

AdventHealth Orlando

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.